Elevian – Reimagine Aging
Elevian – Reimagine Aging Elevian is a Harvard spin-out developing new medicines that target aging. These drugs have the potential to treat and prevent many age-related diseases at the same time and extend healthy longevity. Groundbreaking research by Elevian’s scientific founders has demonstrated that older animals, when transfused with the blood of young animals, experience […]
How to Invest in Biotech Series – Phases, Stages, and Pitfalls
How to Invest in Biotech Series – Phases, Stages, and Pitfalls By Marc Appel, CEO, Orange Grove Bio Emily Whitehead was 5 years old when she was diagnosed with acute lymphoblastic leukemia, a serious yet the most common type of childhood cancer. Her cancer was resistant to traditional treatments and her prognosis was poor. In […]
BioXyTran, Inc. — Tissue Regeneration for Life
BioXyTran, Inc. — Tissue Regeneration for Life Bioxytran Inc. (OTC: BIXT) is a late stage biotechnology company that is developing a first-in-class oxygen treatment platform for victims of brain stroke trauma. The company’s lead drug candidate, BXT-25, is getting ready to proceed to testing. BXT-25 has many properties of an existing, well tested drug, called […]
Orange Grove Bio: Filling the Gap in Preclinical Drug Development
Orange Grove Bio: Filling the Gap in Preclinical Drug Development Future Orange Grove Bio is a preclinical drug development company focused on driving down the cost of drug development and taking advantage of the exceptional science developed at universities across the country. Preclinical biopharma today represents one of the best opportunities in life sciences today. […]
Selecting Therapies for Cancer Patients: Past, Present, and Future
Selecting Therapies for Cancer Patients: Past, Present, and Future Clifford Reid, PhD We are in the middle of a revolution in DNA sequencing, which has ushered in the era of precision medicine in cancer. Unfortunately, the impact of precision medicine has been quite limited, reaching only about 15% of cancer patients, and benefitting only about […]